Ipsen Laura K

SEC source: 0001209191-21-046350 · doc4.xml · derivative · entry 4

Ipsen Laura K · CIK 0001507135 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 705

Underlying: Common Stock · 705 shares

Expires 2031-07-01

F5 · security: The reporting person elected to receive the reported stock options under the Issuer's 2021 Equity Incentive Plan as part of the reporting person's annual retainer.

SEC source: 0001209191-21-046350 · doc4.xml · derivative · entry 3

Ipsen Laura K · CIK 0001507135 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,238

Underlying: Common Stock · 1,238 shares

Expires 2031-07-01

F3 · security: The reporting person was awarded the reported stock options under the Issuer's 2021 Equity Incentive Plan. These stock options vest monthly ratably over a period of 12 months from the grant date.

F4 · derivative.exercise_date: Exercisable upon the earlier of (i) the first anniversary of the grant date or (ii) the end of the reporting person's service to the Board of the Issuer.

SEC source: 0001209191-21-046350 · doc4.xml · nonDerivative · entry 2

Ipsen Laura K · CIK 0001507135 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,362

F2 · security: The reporting person elected to receive these deferred stock units under the Issuer's 2021 Equity Incentive Plan as part of the reporting person's annual retainer. These deferred stock units entitle the reporting person to 445 shares of Common Stock at the end of the reporting person's service to the Board of the Issuer.

SEC source: 0001209191-21-046350 · doc4.xml · nonDerivative · entry 1

Ipsen Laura K · CIK 0001507135 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,917

F1 · security: These deferred stock units of Common Stock were granted under the Issuer's 2021 Equity Incentive Plan. Subject to the terms of the Issuer's 2021 Equity Incentive Plan and the applicable award agreement thereunder, these deferred stock units entitle the reporting person to 785 shares of Common Stock at the end of the reporting person's service to the Board of the Issuer. These deferred stock units vest monthly ratably over a period of 12 months from the grant date.

SEC source: 0001209191-20-041607 · doc4.xml · derivative · entry 2

Ipsen Laura K · CIK 0001507135 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,209

Underlying: Common Stock · 1,209 shares

Expires 2030-07-01

F2 · security: The reporting person was awarded the reported stock options under the Issuer's 2013 Equity Incentive Plan. These stock options vest monthly ratably over a period of 12 months from the grant date.

F3 · derivative.exercise_date: Exercisable upon the earlier of (i) the first anniversary of the grant date or (ii) the end of the reporting person's service to the Board of the Issuer.

SEC source: 0001209191-20-041607 · doc4.xml · nonDerivative · entry 1

Ipsen Laura K · CIK 0001507135 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,132

F1 · security: These deferred stock units of Common Stock were granted under the Issuer's 2013 Equity Incentive Plan. Subject to the terms of the Issuer's 2013 Equity Incentive Plan and the applicable award agreement thereunder, these deferred stock units entitle the reporting person to 718 shares of Common Stock at the end of her service to the Board of the Issuer. These deferred stock units vest monthly ratably over a period of 12 months from the grant date.

SEC source: 0001209191-20-003098 · doc4.xml · derivative · entry 2

Ipsen Laura K · CIK 0001507135 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 769

Underlying: Common Stock · 769 shares

Expires 2029-07-01

F2 · security: The reporting person was awarded the reported stock options under the Issuer's 2013 Equity Incentive Plan. These stock options vest monthly ratably from the grant date through 7/1/2020.

F3 · derivative.exercise_date: Exercisable upon the earlier of (i) 7/1/2020 or (ii) the end of the reporting person's service to the Board of the Issuer.

SEC source: 0001209191-20-003098 · doc4.xml · nonDerivative · entry 1

Ipsen Laura K · CIK 0001507135 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 414

F1 · security: These deferred stock units of Common Stock were granted under the Issuer's 2013 Equity Incentive Plan. Subject to the terms of the Issuer's 2013 Equity Incentive Plan and the applicable award agreement thereunder, these deferred stock units entitle the reporting person to 414 shares of Common Stock at the end of her service to the Board of the Issuer. These deferred stock units vest monthly ratably from the grant date through 7/1/2020.

SEC source: 0000899243-18-015484 · doc4.xml · derivative · entry 2

Ipsen Laura K · CIK 0001507135 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,578 shares

Expires not disclosed

F1 · derivative.exercise_price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration").

F2 · derivative.exercise_price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.

F1 · price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration").

F2 · price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.

F1 · derivative.exercise_date: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration").

F2 · derivative.exercise_date: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.

F1 · derivative.expiration_date: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration").

F2 · derivative.expiration_date: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.

SEC source: 0000899243-18-015484 · doc4.xml · nonDerivative · entry 1

Ipsen Laura K · CIK 0001507135 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration").

F2 · price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.

SEC source: 0001110783-18-000057 · edgar.xml · nonDerivative · entry 1

Ipsen Laura K · CIK 0001507135 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,004

F1 · shares: Represents dividend equivalents with respect to shares of deferred common stock deliverable upon termination as a director under the Monsanto Company Non-Employee Director Equity Incentive Compensation Plan. Deferred common stock and dividend equivalents are credited to a stock unit account in the form of hypothetical shares, which vest in installments on the last day of each plan month during the director's term. Shares of deferred stock that do not vest, because of termination as a director or certain changes in committee roles, are forfeited.

SEC source: 0001110783-18-000028 · edgar.xml · nonDerivative · entry 1

Ipsen Laura K · CIK 0001507135 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,941

F1 · shares: Represents dividend equivalents with respect to shares of deferred common stock deliverable upon termination as a director under the Monsanto Company Non-Employee Director Equity Incentive Compensation Plan. Deferred common stock and dividend equivalents are credited to a stock unit account in the form of hypothetical shares, which vest in installments on the last day of each plan month during the director's term. Shares of deferred stock that do not vest, because of termination as a director or certain changes in committee roles, are forfeited.

SEC source: 0001110783-17-000225 · edgar.xml · nonDerivative · entry 1

Ipsen Laura K · CIK 0001507135 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,877

F1 · shares: Represents dividend equivalents with respect to shares of deferred common stock deliverable upon termination as a director under the Monsanto Company Non-Employee Director Equity Incentive Compensation Plan. Deferred common stock and dividend equivalents are credited to a stock unit account in the form of hypothetical shares, which vest in installments on the last day of each plan month during the director's term. Shares of deferred stock that do not vest, because of termination as a director or certain changes in committee roles, are forfeited.

SEC source: 0001110783-17-000150 · edgar.xml · nonDerivative · entry 1

Ipsen Laura K · CIK 0001507135 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,813

F1 · shares: Represents shares of deferred common stock deliverable upon termination as a director under the Monsanto Company Non-Employee Director Equity Incentive Compensation Plan. Shares of deferred stock are credited in the form of hypothetical shares to a stock unit account in installments on the last day of each plan month during the director's term. Shares of deferred stock not credited to the stock unit account because of termination as a director are forfeited.

SEC source: 0001110783-17-000128 · edgar.xml · nonDerivative · entry 1

Ipsen Laura K · CIK 0001507135 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,637

F1 · shares: Represents dividend equivalents with respect to shares of deferred common stock deliverable upon termination as a director under the Monsanto Company Non-Employee Director Equity Incentive Compensation Plan. Deferred common stock and dividend equivalents are credited to a stock unit account in the form of hypothetical shares, which vest in installments on the last day of each plan month during the director's term. Shares of deferred stock that do not vest, because of termination as a director or certain changes in committee roles, are forfeited.

SEC source: 0001110783-17-000070 · edgar.xml · nonDerivative · entry 1

Ipsen Laura K · CIK 0001507135 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,581

F1 · shares: Represents dividend equivalents with respect to shares of deferred common stock deliverable upon termination as a director under the Monsanto Company Non-Employee Director Equity Incentive Compensation Plan. Deferred common stock and dividend equivalents are credited to a stock unit account in the form of hypothetical shares, which vest in installments on the last day of each plan month during the director's term. Shares of deferred stock that do not vest, because of termination as a director or certain changes in committee roles, are forfeited.

SEC source: 0001110783-17-000032 · edgar.xml · nonDerivative · entry 1

Ipsen Laura K · CIK 0001507135 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,525

F1 · shares: Represents dividend equivalents with respect to shares of deferred common stock deliverable upon termination as a director under the Monsanto Company Non-Employee Director Equity Incentive Compensation Plan. Deferred common stock and dividend equivalents are credited to a stock unit account in the form of hypothetical shares, which vest in installments on the last day of each plan month during the director's term. Shares of deferred stock that do not vest, because of termination as a director or certain changes in committee roles, are forfeited.

SEC source: 0001110783-16-000562 · edgar.xml · nonDerivative · entry 1

Ipsen Laura K · CIK 0001507135 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,466

F1 · shares: Represents dividend equivalents with respect to shares of deferred common stock deliverable upon termination as a director under the Monsanto Company Non-Employee Director Equity Incentive Compensation Plan. Deferred common stock and dividend equivalents are credited to a stock unit account in the form of hypothetical shares, which vest in installments on the last day of each plan month during the director's term. Shares of deferred stock that do not vest, because of termination as a director or certain changes in committee roles, are forfeited.

SEC source: 0001110783-16-000500 · edgar.xml · nonDerivative · entry 1

Ipsen Laura K · CIK 0001507135 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,402

F1 · shares: Represents shares of deferred common stock deliverable upon termination as a director under the Monsanto Company Non-Employee Director Equity Incentive Compensation Plan. Shares of deferred stock are credited in the form of hypothetical shares to a stock unit account in installments on the last day of each plan month during the director's term. Shares of deferred stock not credited to the stock unit account because of termination as a director are forfeited.